Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Transforming the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics.Funding
Funding rounds
Cap Table
Current and past shareholders
| Investor | Round | |
|---|---|---|
|
Blue Bear Ventures |
N/A |